Scott Barman

Vice Chair

Scott Barman

Vice Chair

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Pharmacology and Toxicology

Administration
Department of The Graduate School

Other Duties

Assistant Dean, MCG Academic Affairs, Admissions

Co-Director, Vascular Biology Center

Bio

Dr. Barman currently holds the rank of Regents’ Professor and Vice Chair of Education in the Department of Pharmacology and Toxicology and is the Assistant Dean for Admissions for the Medical College of Georgia at Augusta University. His research area involves studying mechanisms of Pulmonary Arterial Hypertension (PAH).

  • SBARMAN@augusta.edu
  • (706) 721-6352
  • (706) 721-2347
  • CB 3626

Education

  • Ph.D., Physiology, General University of North Dakota, 1986

  • MS, Physiology, General University of North Dakota, 1983

  • BS, Natural Sciences Muhlenberg College, 1980

Courses Taught Most Recent Academic Year

  • BIOM 8120

    Cardiovas Physio & Pharma
  • MEDI 6120

    Foundations of Medicine
  • MEDI 6330

    Healthcare Across the Lifespan
  • MEDI 6150

    MCG YOU+
  • MEDI 6130

    Musculoskeletal/Skin
  • PHRM 8042

    Pharmacology & Therapeutics I
  • PHRM 9020

    Seminar in Pharmacology
  • MEDI 6240

    GI/GU/Endocrine
  • MEDI 5005

    Integrative Science
  • PHRM 8043

    Pharmacology & Therapeutics II

Teaching Interests

Teaching interests include antihypertensive drugs and anti-inflammatory drugs.

Scholarship

Selected Recent Publications

  • Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models., 2023
    Journal Article, Academic Journal
  • Protective role of Cav-1 in pneumolysin-induced endothelial barrier dysfunction., 2022
    Journal Article, Academic Journal
  • Image collection and annotation platforms to establish a multi-source database of oral lesions., 2022
    Journal Article, Academic Journal
  • Galectin-3 Promotes ROS, Inflammation, and Vascular Fibrosis in Pulmonary Arterial Hypertension, 2021
    Book, Chapter in Scholarly Book-New
  • Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia-induced pulmonary hypertension., 2021
    Journal Article, Academic Journal

Research Interests

Investigates signal transduction mechanisms involved in Pulmonary Arterial Hypertension (PAH) mostly associated with Galectin-3 and Protein Z-binding kinase, which have been shown to be associated with cancer development